Investor Relations & Capital Introduction in Laval

Laval is a large city on Île Jésus, just north of Montreal, and the third-largest city in Quebec. For founders, it offers a strong biotechnology and pharmaceutical cluster and access to Montreal's investors.

Why Laval Matters for Capital Raising

Laval was created in 1965 by merging the municipalities of Île Jésus into a single city.

The Cité de la Biotech in Laval hosts pharmaceutical companies, research centres and biotech startups, including the Armand-Frappier institute of INRS.

Laval benefits from Quebec's research tax credits and close links to Montreal's universities and venture funds.

What Laval Investors Examine

For biotech and pharmaceutical companies, scientific data and regulatory pathways are examined closely.

Investors value experienced management and strong partnerships.

The Laval Startup and Investor Ecosystem

Laval's economic heart is its Centropolis district and the area around the metro extension from Montreal, where offices, retail and new residential development have grown together. The Université de Montréal operates a campus in Laval, and Collège Montmorency trains technicians and applied science students for local employers.

Alongside the biotech cluster, the city has a substantial base of light manufacturing, distribution and food processing companies, helped by its position on the highway network linking Montreal with the Laurentians and northern Quebec. Many businesses in Laval are family-owned firms serving the wider Montreal market.

Laval founders draw heavily on the Greater Montreal capital market, including provincially backed investors such as Investissement Québec and the Fonds de solidarité FTQ, as well as Montreal's life sciences and technology venture funds.

Investor Types Active in Laval

Laval sees activity from Montreal's life sciences venture funds, pharmaceutical companies acting as corporate investors and partners, and provincial institutions that support Quebec-based growth companies. Family offices and private investors with roots in real estate, distribution and manufacturing also back local businesses. Investors here tend to value strong scientific foundations, clear commercial partnerships and companies that maintain a meaningful presence in Quebec.

Engagement and Access

GCN connects founders with Laval investors, life sciences partners and the wider Montreal investor community through conference programming and private sessions.

Sectors where we see consistent Laval interest include biotechnology and pharmaceuticals, advanced manufacturing, logistics, real estate and consumer brands.

Partner with Global Capital Network

Whether you are raising into Laval or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.